Novan Inc

NASDAQ:NOVN   3:59:54 PM EDT
6.89
-0.24 (-3.37%)
Products, Regulatory

Novan Reports Safety Data From B-SIMPLE4 Pivotal Phase 3 Study Of SB206

Published: 09/23/2021 12:27 GMT
Novan Inc (NOVN) - Novan Reports Safety Data From B-simple4 Pivotal Phase 3 Study of Sb206.
Novan Inc - Sb206 Demonstrates Continued Favorable Safety Profile Consistent With Previous Studies and Meets Company's Expectations.
Novan Inc - Pre-nda Meeting With FDA, As Well As Conduct of Customary Stability Testing, Targeted for 1h 2022.
Novan Inc - Potential NDA Submission on Track, Targeting Q3 2022.